Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- Check4 days agoChange DetectedA new history entry dated 2026-07-31 with a Study Status update was added (preceded by a 2026-07-30 entry); the 2026-07-06 entry was removed.SummaryDifference0.2%

- Check11 days agoChange DetectedRevision: v3.6.4 has been added and the previous revision v3.6.3 has been removed, updating the page’s version label. This reflects a new page revision in the history.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new version entry (91) dated 2026-07-02 and a separate 'Study Status' note dated 2026-07-06 were added to the history, while a 2026-06-05 entry was removed from the history.SummaryDifference0.2%

- Check32 days agoChange DetectedThe history list now displays Revision: v3.6.3, replacing Revision: v3.6.2. This indicates a new iteration of the record history.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page history shows the site revision updated from v3.6.0 to v3.6.2, indicating a newer UI version in the Record History. This update does not alter study data or listings.SummaryDifference0.0%

- Check54 days agoChange DetectedRecruitment status updated to not currently enrolling participants. The record's revision tag was updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.